MedPath
HSA Approval

DOPEZIL TABLETS 5MG

SIN14390P

DOPEZIL TABLETS 5MG

DOPEZIL TABLETS 5MG

July 31, 2013

RANBAXY (MALAYSIA) SDN. BHD.

RANBAXY (MALAYSIA) SDN. BHD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRANBAXY (MALAYSIA) SDN. BHD.
Licence HolderRANBAXY (MALAYSIA) SDN. BHD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N06DA02

donepezil

Manufacturer Information

RANBAXY (MALAYSIA) SDN. BHD.

SUN PHARMACEUTICAL INDUSTRIES LIMITED

Active Ingredients

Donepezil 4.56mg equivalent to Donepezil Hydrochloride

5.00mg

Donepezil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DOPEZIL TABLETS 5MG - HSA Approval | MedPath